Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flavio Caprioli

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
The New England Journal of Medicine|July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's DiseaseLaurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Inflammatory Bowel Diseases|June 30, 2023
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD StudyFabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, et al.
European Journal of Gastroenterology & Hepatology|October 1, 2019
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' studyAnna Viola, Rita Monterubbianesi, Giuseppe Scalisi, et al.
Cancers|December 24, 2021
Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free ControlsMassimiliano Mutignani, Roberto Penagini, Giorgio Gargari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2024
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
Journal of Crohn'S & Colitis|April 1, 2025
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort studyDaniele Noviello, María Chaparro, Chiara Viganò, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
The New England Journal of Medicine|July 17, 2024
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's DiseaseLaurent Peyrin-Biroulet, J Casey Chapman, Jean-Frederic Colombel, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Gut|May 2, 2020
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD studyCristina Bezzio, Simone Saibeni, Angela Variola, et al.
Inflammatory Bowel Diseases|June 30, 2023
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD StudyFabio Salvatore Macaluso, Mariabeatrice Principi, Federica Facciotti, et al.
European Journal of Gastroenterology & Hepatology|October 1, 2019
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' studyAnna Viola, Rita Monterubbianesi, Giuseppe Scalisi, et al.
Cancers|December 24, 2021
Blood Bacterial DNA Load and Profiling Differ in Colorectal Cancer Patients Compared to Tumor-Free ControlsMassimiliano Mutignani, Roberto Penagini, Giorgio Gargari, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2024
Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD)Gaetano Bergamaschi, Fabiana Castiglione, Renata D'Incà, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
Journal of Crohn'S & Colitis|April 1, 2025
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort studyDaniele Noviello, María Chaparro, Chiara Viganò, et al.
Pageof 18